Key facts
- This page summarizes Pharis Mohideen's Form 4 filing for DBV Technologies S.A. (DBVT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jul 2026, 16:15.
Pharis Mohideen - 29 Jul 2026 Form 4 Insider Report for DBV Technologies S.A. (DBVT)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- DBVT
- Reported as of
- 29 Jul 2026
- Net transaction value
- -$1,253
- SEC form
- 4
- Accepted by SEC
- 31 Jul 2026, 16:15:05 UTC
- Prior SEC filing
- 02 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Virginie Boucinha, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Pharis Mohideen filed Form 4 for DBV Technologies S.A. (DBVT) on 31 Jul 2026.
Change
- Previous filing in this sequence was filed on 02 Feb 2026.
- Current net transaction value: -$1,253.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001760395
Primary reporting owner
Mohideen Pharis
- Relationship
- Chief Medical Officer
- Address
- C/O DBV TECHNOLOGIES S.A., 107, AVENUE DE LA REPUBLIQUE, CHATILLON, FRANCE
- Signature
- /s/ Virginie Boucinha, Attorney-in-Fact
- Signature date
- 31 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DBVT
transaction
Ordinary Shares
Sale
- Transaction value
- $1,253
- Shares
- -464
- Change %
- -0.32%
- Price
- $2.70
- Shares after
- 144,531
- Date
- 29 Jul 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
Footnote F2
Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
Footnote F3
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1380 to EURO 1.00 as of July 29, 2026.